Samples of vital human tumor tissue irradiated with ions for the first time

December 17, 2010

Cancer treatment with ion beams developed at GSI is characterized by an excellent cure rate and only minor side effects. The therapy has been routinely in use for a little over one year. The effectiveness of the ion beams not only depends on the tumor type, but also on the genetic disposition and the personal circumstances of the individual patient. For the first time, scientists at GSI Helmholtzzentrum für Schwerionenforschung have irradiated samples of vital human tumor tissue in the scope of their systematical and fundamental research. Their long-term goal is to enhance the already highly effective ion beam therapy in a way that allows the optimization of the irradiation dose based on the specific tumor of the individual patient. Such a treatment would constitute a novel approach, as radiation treatment so far only considered the type and position of the tumor.

This research is only possible because the University of Frankfurt was able to produce samples of specific human tumors for the first time. The patient-derived tumor tissue is prepared in a way that keeps the tissue sample vital for several weeks. The fact that these samples are consistent with their natural environment allows the scientists to observe the effects of the radiation that occur in the treatment of patients. One of the points the researchers are examining is the so-called "bystander effect" -- the effect that the irradiated cells have on their neighboring cells. Previous tests on artificial cell samples and animal experiments were very limited in this respect.

This cancer therapy developed at GSI has already proven highly effective, with very few side effects. "However, every tumor reacts differently to irradiation: some are more sensitive, stop growing or perish, others are more resistant and remain unaffected by the therapy. The effectiveness of the therapy varies from patient to patient", says Professor Marco Durante, head of the biophysics department at GSI Helmholtzzentrum. "The irradiation and subsequent analysis of a tissue sample taken from the patient allows us to find out about the tumor's characteristics. And based on this knowledge, the attending physician can optimize the tumor therapy for the individual patient."

Human tissue samples are typically obtained during surgery. A new method now makes it possible to keep those tissue samples vital in the laboratory over several weeks. "These so-called tissue slice cultures are used as a model system for biological studies, because they allow us to look beyond the events that occur in a single cell and help us study the tumor cells in their natural environment surrounded by other cells", explains professor Ingo Bechmann, who helped develop this new system at Charité in Berlin and Frankfurt University and who now holds a professorship at Leipzig University. Dr. Kosta Schopow, the Frankfurt-based physician and curator of the Senckenberg Foundation, had the idea of using tissue slice cultures for the research at GSI.
-end-
The first research results from the irradiation of tissue slice cultures at GSI have already been published:

- Modeling radiation effects at the tissue level / The European Physical Journal D (2010), DOI: 10.1140/epjd/e2010-00030-y, Müller et al

- Tissue slice cultures from humans or rodents: a new tool to evaluate biological effects of heavy ions / Radiation and Environmental Biophysics (2010), DOI: 10.1007/s00411-010-0293-1, Merz et al

Helmholtz Association

Related Radiation Articles from Brightsurf:

Sheer protection from electromagnetic radiation
A printable ink that is both conductive and transparent can also block radio waves.

What membrane can do in dealing with radiation
USTC recently found that polymethylmethacrylate (PMMA) and polyvinyl chloride (PVC) can release acidic substance under γ radiation, whose amount is proportional to the radiation intensity.

First measurements of radiation levels on the moon
In the current issue (25 September) of the prestigious journal Science Advances, Chinese and German scientists report for the first time on time-resolved measurements of the radiation on the moon.

New biomaterial could shield against harmful radiation
Northwestern University researchers have synthesized a new form of melanin enriched with selenium.

A new way to monitor cancer radiation therapy doses
More than half of all cancer patients undergo radiation therapy and the dose is critical.

Nimotuzumab-cisplatin-radiation versus cisplatin-radiation in HPV negative oropharyngeal cancer
Oncotarget Volume 11, Issue 4: In this study, locally advanced head and neck cancer patients undergoing definitive chemoradiation were randomly allocated to weekly cisplatin - radiation {CRT arm} or nimotuzumab -weekly cisplatin -radiation {NCRT arm}.

Breaking up amino acids with radiation
A new experimental and theoretical study published in EPJ D has shown how the ions formed when electrons collide with one amino acid, glutamine, differ according to the energy of the colliding electrons.

Radiation breaks connections in the brain
One of the potentially life-altering side effects that patients experience after cranial radiotherapy for brain cancer is cognitive impairment.

Fragmenting ions and radiation sensitizers
The anti-cancer drug 5-fluorouracil (5FU) acts as a radiosensitizer: it is rapidly taken up into the DNA of cancer cells, making the cells more sensitive to radiotherapy.

'Seeing the light' behind radiation therapy
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime.

Read More: Radiation News and Radiation Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.